US OptionsDetailed Quotes

EYE240517C25000

Watchlist

0.05
0.000.00%

15min DelayTrading Apr 8 11:53 ET

0.00High0.00Low

National Vision Stock Discussion

Kevin Travers

Feb 28 00:02

ColumnsBiotechnology Stocks Climbing on Earnings and Test Results: What to Watch

$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks.
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...

Moomoo AI

Feb 23 22:25

The drop in share price and EPS indicates potential unresolved challenges within the company. Despite the insider purchases, investors are advised to ensure they are buying into a high quality business before making any decisions.

Shareholders in National Vision Holdings (NASDAQ:EYE) Have Lost 58%, as Stock Drops 3.7% This Past Week

Moomoo AI

Feb 7 18:20

The chance to purchase National Vision Holdings at a favorable price has vanished. With future negative growth uncertainty, it might be time to lessen portfolio risk. The high beta of the stock suggests prices could drop further, possibly providing another buying opportunity later.

When Should You Buy National Vision Holdings, Inc. (NASDAQ:EYE)?

SanjBot

Jan 17 16:25

$National Vision(EYE.US)$Here's Why You Should Retain National Vision (EYE) Stock Now

Moomoo AI

Dec 27, 2023 23:28

Overall insider investment shows confidence in company's ops and finances, but shareholders advised not to use insider transactions as sole measure of potential investment value.

Bullish National Vision Holdings Insiders Loaded Up On US$1.39m Of Stock

Moomoo AI

Nov 4, 2023 02:16

Stock's performance may signify internal challenges. Investors should ensure business quality before investing. The current downward shares trend amid profitability growth demands careful evaluation.

Strong Week for National Vision Holdings (NASDAQ:EYE) Shareholders Doesn't Alleviate Pain of Three-year Loss

Moomoo AI

Oct 7, 2023 22:53

Despite National Vision Holdings reinvesting for growth, it may not become a multi-bagger. Market skepticism persists as earnings improvements from these investments may take time.

National Vision Holdings (NASDAQ:EYE) Might Be Having Difficulty Using Its Capital Effectively

Analysts Notebook

Jun 27, 2022 20:02

ColumnsTop upgrades and downgrades on 6/27: ETSY, CHWY, BBBY, GTLB and more

Upgrades
• $AutoZone(AZO.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $2,296 (from $1,969)
• $Chewy(CHWY.US)$ : Needham Upgrades to Buy from Hold - PT $55
• $National Vision(EYE.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $32 (from $31)
• $Fresenius Medical Care(FMS.US)$ : Jefferies Upgrades to Buy from Underperform - PT $33.70 (from $30.30)
• $Gitlab(GTLB.US)$ : Goldman Sachs Upgrades to Buy from Neutral - ...

efficentupup

Jun 14, 2022 20:31

Stocks making the biggest moves in the premarket (1) :

$Continental Resources(CLR.US)$ – The oil and natural gas producer’s stock rallied 7.4% in the premarket after receiving a $70 per share “take private” bid from Chairman Harold Hamm and his family. The company’s board will establish an independent committee to evaluate the proposal.
$Oracle(ORCL.US)$ – Oracle surged 12% in premarket trading after reporting better-than-expected profit and revenue for its latest quarter. Oracle is seeing strong dema...

No comment yet